The GHA and UL Solutions would like to invite you to join the upcoming webinar on Tackling Medical Compliance in 2023. In this webinar, we will be discussing several important topics that are crucial for anyone working in the medical industry.

First, we will be exploring the IEC 60601 amendment 2, which brings significant changes to the standard that affects many medical devices. We will help attendees identify which areas of their devices are relevant to the amendment and how they can ensure compliance.

Next, we will delve into the topic of Home Healthcare, which has become an increasingly important area of medical device development. We will discuss the applicable standards and the key challenges that come with it.

Finally, we will cover the latest revisions to ISO 10993, including part 17 on chemical characterization and part 18 on extractables and leachables. These updates are essential for anyone working with toxicological risk assessment.

This webinar will be held in English and free of charge.

Topic: Tackling medical compliance in 2023

• IEC 60601 amendment 2
• Home Healthcare
• Toxicological risk assessment (ISO 10993)

The detailed programme will be published here soon.

We look forward to discussing these topics with you.

———————————————————————————————————————————

About UL Solutions
UL Solutions is a GHA member and a global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers in more than 100 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers’ product innovation and business growth.

The UL Certification Marks serve as a recognized symbol of trust in our customers’ products and reflect an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains and grow sustainably and responsibly into the future. Our science is your advantage.

———————————————————————————————————————————

Registration